Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer

OBJECTIVE: Better biomarkers are needed in order to identify patients with endometrial carcinoma at risk of recurrence and who may profit from a more aggressive treatment regimen. Our objective was to explore the applicability of plasma growth differentiation factor 15 (GDF-15) as a marker for recur...

Descripción completa

Detalles Bibliográficos
Autores principales: Engerud, Hilde, Hope, Kirsten, Berg, Hege Fredriksen, Fasmer, Kristine Eldevik, Tangen, Ingvild Løberg, Haldorsen, Ingfrid Salvesen, Trovik, Jone, Krakstad, Camilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333370/
https://www.ncbi.nlm.nih.gov/pubmed/30645608
http://dx.doi.org/10.1371/journal.pone.0210585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333370/
https://www.ncbi.nlm.nih.gov/pubmed/30645608
http://dx.doi.org/10.1371/journal.pone.0210585

Ejemplares similares